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Abstract
Background: Reduced diastolic myocardial function is an early sign of diabetic cardiomyopathy. The aim of this
study was to test the hypothesis that children and adolescents with type 1 diabetes mellitus (T1D), but without
other known complications, have early reduced diastolic myocardial function diagnosed with echocardiographic
color tissue Doppler imaging (cTDI).
Methods: cTDI examination was carried out in 173 T1D patients and 62 age-matched controls. The T1D-patients
were 8–18 years old with (mean (SD)) diabetes duration of 5.6 (3.4) years and HbA1c of 8.4 (1.3). All were treated
with either insulin pumps or 4–6 daily insulin injections. cTDI early (E’) and late (A’) peak diastolic velocities and
systolic peak velocity were measured from the lateral, septal, anterior and posterior mitral annulus and from the
lateral tricuspidal annulus.
Results: Myocardial diastolic function was reduced in the T1D-patients with higher peak A’-velocity and lower
E’/A’-ratio in all registrations. Overall mean (SD) mitral E’/A’-ratio was 2.3 (0.5) in T1D and 2.7 (0.6) in the controls
(p < 0001). The overall mitral E’/A’-ratio was negative associated with blood pressure (BP) and body mass index
(BMI). Stratifying all participants into three groups according to BMI (<25, 25–75, >75 centile, respectively), the T1D
had lower E’/A’-values in all stratified groups, except for in the highest BMI-group where both T1D and controls had
the lowest E’/A’-ratio. Systolic function did not differ in any of the measurements. There were no associations with
sex, diabetes duration, carotid artery intima-media-thickness, vessel elasticity or HbA1c.
Conclusion: Diabetic children and adolescents using modern intensive insulin treatment had echocardiographic
signs of reduced diastolic myocardial function despite short duration of disease. The reduced function was
associated with higher BP and higher BMI.
Keywords: Diabetes type-1, Tissue Doppler imaging, Echocardiography, Diastolic myocardial function, Body mass
index, Blood pressure
Background
Clinical and experimental studies have demonstrated
evidence of diabetic cardiomyopathy independent of cor-
onary artery disease and hypertension [1, 2]. Diabetes
cardiomyopathy is strongly associated with adverse prog-
nosis in adults [3–5]. Diabetic cardiomyopathy can affect
diastolic function, systolic function, or both [1]. Reduced
systolic and diastolic function has been demonstrated in
adults with diabetes without known diabetic cardiomy-
opathy [6–8]. However, the process probably starts in
early childhood and may affect both ventricles [9, 10].
The preclinical stage is suggested to primarly consist of
reduced diastolic function. It may be demonstrated with
tissue Doppler imaging (TDI) techniques long before it
can be detected by 'conventional echocardiographic
methods [11–14]. TDI seems to be the most powerfull
echocardiographic method to evaluate diastolic function
in T1D [15, 16]. Diabetic cardiomyopathy has also been
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assosciated with reduced elasticity of the great arterial
vessels [17].
We hypothesized that diastolic myocardial dysfunction
is present at an early stage of T1D despite treatment
with modern intensified insulin regimens and no signs
of microvascular complications. The aim of this study
was to explore the diastolic myocardial function in chil-




All children and adolescents with T1D aged 8–18 years
in Health Region South-East in Norway (n = 800) were
invited to participate in a study focusing on cardiovascu-
lar risk factors and early signs of atherosclerosis. Forty
percent of the invited (n = 314) agreed to participate and
were compared with 118 age-matched healthy control
subjects. The diabetic cohort was found to be represen-
tative of the childhood T1D-population in Norway.
None of the diabetic patients had signs of renal, retinal
or neurological complications of the disease and all were
using intensified insulin treatment (more than four daily
insulin injections or insulin pumps). Results from the
main study have been published earlier [18]. Out of this
main study population a sub-study was conducted to
evaluate the myocardial function with echocardiographic
TDI examination. The enrolment in this sub-study was
at random and depended only on the availability of at
least one of the two pediatric cardiologists to perform
the echocardiographic examination on the same day as
the other investigations were taking place. All partici-
pants that were asked to participate in this echocardio-
graphic sub-study agreed, and so 173 T1D and 62
control subjects were included.
Ethical issues
Written informed consent was obtained from all the par-
ents and from the participants when older than 12 years
of age. The study protocols were approved by the
Regional Committee for Medical and Health Research
Ethics South East, Norway and the Norwegian Social
Science Data Services.
Baseline characteristics and laboratory measurements
The baseline measurements of blood pressure (BP),
weight and height were recorded, and body mass index
(BMI) was calculated as the ratio of the individual’s body
weight to the square of the height. Arterial BP was mea-
sured according to the National High Blood Pressure
Education Program Working Group on High Blood
Pressure in Children and Adolescents [19].
Glycated hemoglobin (HbA1c) was determined for all
participants by liquid chromatography (Variant; Bio-Rad,
Richmond, CA) at the Department of Clinical Chemistry
at Oslo University Hospital, Aker. The normal reference
range was 4.1–6.4 (±2 %), and the intra-assay coefficient
of variation was <3 %. Annual HbA1c values were avail-
able from the Norwegian Childhood Diabetes Registry
since 2001 or from the time of diagnosis for the majority
of the patients. Mean HbA1c was calculated from all the
HbA1c values available for each patient [18].
Echocardiography
Two experienced pediatric cardiologists (DF and LB)
performed all echocardiographic examinations by use of
a Vivid 7 scanner (GE, Horten, Norway) with a standard
phase-array multi-frequency transducer (5 S probe, GE,
Horten, Norway) transmitting at 2.4 MHz. The children
were awake and relaxed in a left semi-lateral supine pos-
ition. A structured sequential two-dimensional echocar-
diogram was made from subcostal, apical, parasternal
long and short-axis and supra-costal views to rule out
structural heart defects [20]. Tissue Doppler images
(TDI) of the left ventricle (LV) and right ventricle (RV)
were recorded from standard apical two and four cham-
ber views using a tissue velocity range of ±0.22m/s. In
all images, the sector angle was 30° or less and the tissue
Doppler frame rate was 170–220/s. For each view, three
to five consecutive cardiac cycles were recorded. ECG
was recorded simultaneously. Septum length was mea-
sured in B-mode four-chamber view from the apical epi-
cardium to the sepal attachment of the mitral valve.
From the apical 4-chamber view, the peak pulsed
blood flow mitral valve annulus early diastolic (E) and
late diastolic (A) velocities were measured with the sam-
ple volume positioned at the tip of the mitral leaflets
and at an angle as parallel to mitral flow as possible.
EchoPac software (EchoPac PC SW, GE, Horten,
Norway) was used for post processing of the TDI indices
by color TDI (cTDI). cTDI early diastolic peak velocity
(E’), atrial peak velocity (A’), E’/A’-ratio and systolic peak
velocity were analyzed from the lateral, septal, anterior
and posterior mitral annulus and from the lateral tricus-
pidal annulus. The region of interest (ROI) was set to
3x1 mm. Measurements were made with the ROI placed
stationary in the ultrasound sector at the atrioventricular
valve insertion. If artifacts occurred, the ROI was slightly
repositioned in order to minimize background noise. If
background noise could not be reduced, the recording
was defined as poor quality and excluded from further
analysis. Peak systolic velocity (cTDI S´) was measured
at the maximum height of the systolic velocity curve.
Common carotid artery ultrasound
A standard ultrasonic protocol was used for measuring
the common carotid artery intima-media thickness
(cIMT) and the elasticity of the artery [21], as described
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earlier [18]. The distensibility reflects the mechanical
load on the artery wall and is generally expressed as
changes in lumen cross-sectional area (A) during the
cardiac cycle. The distensibility coefficient (DC) as a
measure of elasticity was calculated from the expression
(DC = (ΔA/A)/ ΔP = ((d +Δd)2-d2)/d2/Δp). Δp repre-
sents the change in pulse pressure, d the end-diastolic
diameter (including the intima-media complex) and Δd
the change in diameter from diastole to systole, assum-
ing a circular lumen cross-section of the vessel [18].
Statistical analysis
Demographic and clinical data are presented as percent-
ages or means with their standard deviations. Means
were compared with student’s t-test when the data was
normally distributed, otherwise with Mann–Whitney U
test. The participants were stratified with respect to BMI
into three different groups; group I (levels <25 centile),
group II (levels between 25–75 centile) and group III
(levels >75 centile). The differences within the stratified
groups were tested with student’s t- test or Mann–Whit-
ney U test. Correlation was tested with Pearson’s linear
regression method.
Results
The demographic data and baseline measurements of
HbA1c, systolic and diastolic BP, cIMT as well as DC
calculations are presented in Table 1. The echocardio-
graphic cTDI and blood flow velocity parameters are
presented in Tables 2 and 3. The calculated E´/A´-ratio
and BP stratified according to the three BMI-groups are
presented in Table 4. Echocardiographic recording de-
fined as poor quality was excluded from further analysis.
Complete datasets were achieved in 146 of the 173 T1D-
participant and in 56 of the 62 controls.
Myocardial diastolic function was reduced in the T1D.
The mean value for E’/A’-ratio was lower in T1D popu-
lation compared to the controls in all registrations from
the mitral and the lateral tricuspidal annulus ring
(Tables 2 and 3). The overall E’/A’-ratio from the mitral
annulus ring was 2.3 in the diabetic group and 2.7 in the
controls (p < 0001) (Table 3). The mitral E’/A’-ratio was
also negative associated with systolic and diastolic BP
and BMI, but there were no associations with sex, years
after the diagnosis of diabetes and HbA1c. There were
no differences in the mean mitral value for E/E’-ratio or
Table 1 Demographic and metabolic parameter presented as %
or mean (SD)
Parameter T1D control p value
n = 173 n = 62
Age (years) 13.6 (2.8) 13.0 (2.6) ns
Sex (boy/girl) 86/87 21/41
Height (cm) 159.8 (14.6) 154.4 (14.1) 0.01
Weight (kg) 54.8 (17.0) 45.8 (14.4) <0.001
Body mass index (kg/m2) 20.9 (4.1) 18.8 (3.6) <0.001
Systolic blood pressure (mmHg) 101.1 (9.7) 96.5 (10.5) 0.002
Diastolic blood pressure (mmHg) 61.3 (8.4) 56.8 (7.4) <0.001
Duration of T1D (years) 5.6 (3.4) -
Serum creatinine (μmol/l) 53.0 (10.5) 53.1 (10.3) ns
Urinary albumin/creatinine 1.2 (2.1) 1.5 (2.3) ns
HbA1c (%) 8.4 (1.3) 5.3 (0.29)
Mean HbA1c (%) 8.0 (0.96)
CRP(mg/L) 1.9 (3.7) 1.0 (3.1) ns
cIMT (mm) 0.48 (0.05) 0.48 (0.05) ns
DC (kPa−1) 0.044 (0.02) 0.046 (0.01) ns
Table 2 Measurement of cardiac blood flow and cTDI
T1D control p value
n = 146 n = 56
MV E (m/s) 0.93 (0.16) 0.92 (0.16) ns
MV A (m/s) 0.43 (0.11) 0.41 (0.11) ns
E/A 2.3 (0.7) 2.4 (0.9) ns
E/E’ 8.1 (1.6) 7.6 (1.4) ns
Septum length (cm) 8.7 (1.1) 8.2 (1.1) 0.007
MV lateral E’/A’ 3.2 (1.3) 3.6 (1.4) 0.02
MV septum E’/A’ 2.1 (0.7) 2.3 (0.6) 0.007
MV inferior E’/A’ 2.3 (0.6) 2.7 (0.9) <0.001
MV anterior E’/A’ 2.3 (0.7) 2.8 (0.6) <0.001
TV E’/A’ 1.6 (0.6) 1.8 (0.6) 0.009
Mitral valve (MV), tricuspidal valve (TV), maximal early diastolic flow across the
valve (E), maximal late diastolic flow across the valve (A), maximal early
diastolic velocity of the annulus (E’), maximal late diastolic velocity of the
annulus (A’), maximal systolic velocity of the annulus (S’). All the
measurements were performed with the probe in a standard apical position.
All data presented in mean (SD)
Table 3 Maximal velocities
T1D control p value
n = 146 n = 56
MV S’ (cm/s) 7.0 (1.0) 6.9 (1.0) ns
MV E’ (cm/s) 11.7 (1.4) 12.1 (1.5) ns
MV A’ (cm/s) −5.2 (1.0) −4.6 (1.0) 0.006
MV E'/A’ 2.3 (0.5) 2.7 (0.6) <0.001
TV S’ (cm/s) 10.6 (1.6) 10.8 (1.7) ns
TV A’ (cm/s) −8.1 (2.5) −7.2 (2.3) 0.03
TV E’ (cm/s) −11.7 (2.1) −12.0 (1.8) ns
Mitral valve (MV), tricuspidal valve (TV), maximal early diastolic flow across the
valve (E), maximal late diastolic flow across the valve (A), maximal early
diastolic velocity of the annulus (E’), maximal late diastolic velocity of the
annulus (A’), maximal systolic velocity of the annulus (S’). All the
measurements were performed with the probe in a standard apical position.
All data presented in mean (SD)
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in systolic function (S´) between the diabetic and non-
diabetic group.
The T1D population stratified into BMI group I and II
had significant lower E’/A’-ratio than the controls. Those
in the highest stratified group also had the lowest E’/A’-
ratio, but with no differences between the diabetic and
non-diabetic population. There were no differences be-
tween diabetic and non-diabetic groups regarding sys-
tolic or diastolic BP, septum length or height. There
were no differences regarding sex, age, diabetes duration
and HbA1c, nor any differences regarding systolic func-
tion (S´).
There were no association between E’/A’-ratio and
cIMT and no differences between the diabetic and
non-diabetic population regarding cIMT. However, a
small but significant positive correlation was found
between DC and E’/A’-ratio for the whole group (r2 = 0.05,
p = 0.003). Separated into those with diabetes or not,
there was still an association in the T1D group (r2 = 0.06,
p = 0.003), but not in the control group.
Discussion
The main finding in this study was that children and ad-
olescents with T1D had lower E’/A’-ratio in all measure-
ments from the mitral and lateral tricuspidal annulus
ring. This confirms that even young children and adoles-
cence with insulin dependent diabetes, but with no signs
of diabetic comorbidity, have a small, but significant re-
duction of the diastolic myocardial function [22, 23]. In
contrast to one earlier study [24], we could not find any
differences between sexes. This is in accordance with a
study of long-term T1D patients from Oslo [25], and
also with other studies in children and adolescents [26].
The mean mitral E’/A’-ratio was negatively associated
with BMI. This difference was still present in the lower
and in middle BMI groups when stratified into different
groups of BMI. Both the T1D and controls in the highest
BMI group (group III) had the lowest E’/A’-ratio of all,
but there was no differences between the control and
diabetic group (Table 4). However, the result is uncertain
due to lack of power in this control group (Table 4). A
high BMI seems to be an independent risk factor for re-
duced diastolic function as also demonstrated by other
authors [24, 26]. The small, but significant positive cor-
relation between DC and E’/A’-ratio shows that E’/A’-ra-
tio to some extent may reflect a reduced elasticity in
both the atrial wall and the wall of the common carotid
artery.
We did not find any associations between E’/A’-ratio
and diabetes duration or HbA1c as demonstrated by
others [6]. This may reflect the young age of the partici-
pants and the short duration of the disease in our study
and that their diabetes seems to be under fair blood glu-
cose control.
Interestingly we did not find any differences in E/E’-ra-
tio. E/E’-ratio is a marker of elevated diastolic left ven-
tricle and left atrium pressure [16]. This might reflect
that the T1D-children in our study only had a small re-
duction in their diastolic function.
There were no differences in measured S’ between
children with and without diabetes. S’ reflects the sys-
tolic longitudinal function of the heart and our findings
is in harmony with other papers. It support the hypoth-
esis that diabetes cardiomyopathy debuts with a reduced
diastolic function, while the systolic function is pre-
served until a more advanced stage of the disease.
Conclusion
Children and adolescents with type 1 diabetes using
modern intensive insulin treatment had echocardio-
graphic signs of reduced diastolic myocardial function
despite short duration of disease. The reduced function
was associated with higher blood pressure and higher
body mass index both in the diabetic and in the non-
diabetic groups.
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